The Information Standard for Blood and Transplant (ISBT) 128 is a global standard for the identification, labelling and information transfer of medical products of human origin.
The National Blood Authority (NBA) has directed the Blood Service to move to this standard in order to meet international benchmarking standards for product identification.
Work on the implementation of the ISBT 128 labelling standard is now underway, and it is expected that customers will begin to see the new ISBT ‘Transition Label’ on blood products by June 2018.
The standard has been designed to ensure the highest levels of accuracy, safety, and efficiency for the benefit of donors, patients and health providers.
The Blood Service has recently published the results of our recently completed hepatitis E virus (HEV) RNA prevalence study. HEV is a known transfusion-transmissible agent.
Blood Service in Brief July Edition is here! We're celebrating 50 years of anti-D, preparing for the ISBT 128 Transition Label, helping health professionals with new audit tools and more.
Blood Prescriber App is an updated version of the Red Cell Prescriber App - and now includes platelets. The purpose of the app is to assist health professionals, particular junior doctors, in the appropriate, evidence-based prescription of red cells and platelets for transfusion.